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Background
Non-infectious diseases that rarely receive 
special attention are degenerative diseases because 
they are thought to occur due to the aging process. 
One disease that is considered a degenerative disease 
is low back pain (LBP). Lower back pain is a health 
problem that is often found in industrialized countries 
and developing countries, where the recovery of a low 
back can be resolved with only needing a few days 
or a few weeks, except about 6–10% can develop or 
become chronic [1]. Lower back pain is a very common 
world health problem that causes limit activity and also 
absence from work. Lower back pain does not cause 
death but involves individuals who experience it to be 
unproductive so that it will create a huge economic 
burden for individuals, families, communities, and 
governments [2].
In this era of globalization, humans are 
required to work faster to fulfill their need for life so that 
it can cause static work cycle in the long term, such as 
sitting in front of a computer for hours and not paying 
attention to the position of the body that works well. This 
can cause complaints of low back pain and decrease 
work productivity [3]. The increasing prevalence of 
musculoskeletal pain including LBP has become an 
epidemic. An estimated 70–85% of the entire population 
has experienced an episode of LBP.
C-reactive protein (CRP) is an acute-phase 
reactant protein substance whose levels increase 
dramatically during the process of infection/inflammation 
that occurs in the body. This increase in CRP occurs 
due to increasing in the levels of interleukin-6 (IL-1) in 
the plasma that is produced by macrophages around 
the intervertebral disc tissue. Therefore, CRP is usually 
used as a parameter to evaluate infection/inflammation 
of the first jam after infection/inflammation [4], [5]. Like 
in osteoarthritis, degenerative changes are the cause of 
lower back, thereby it is suggested that the severity of 
pain is associated with high sensitivity CRP (hs-CRP) 
levels [6]. Subclinical increases hs-CRP probably due 
to local inflammation of soft tissue resulting in pain and 
increases levels of hs-CRP. Besides acute infections 
and unknown systemic inflammatory conditions, 
characteristic factors such as age, body mass index, 
smoking, diabetes, and alcohol consumption are 
known or affect hs-CRP levels. Therefore, to interpret 
the relationship between pain and hs-CRP these 
characteristic factors must be taken into account.
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Abstract
BACKGROUND: A strictly mechanical and pathoanatomical explanation for low back pain (LBP) and sciatica has 
proved inadequate; therefore, the role of biochemical and inflammatory factors remains under investigation.
AIM: The aim of this study is to evaluate whether there is any association between serum levels of high sensitivity 
C-reactive protein (hs-CRP), interleukin-1 (IL-1), and IL-6 with pain intensity in a patient with LBP without sciatica.
METHODS: Venous blood serum levels of hs-CRP, IL-1, and IL-6 were measured on 50 patients with LBP who had a 
negative Lasègue test on physical examination. The pain intensity was measured using a visual analog scale (VAS).
RESULTS: There were 50 patients with LBP without sciatica with mean of age of46.72 ± 10.79-year-old participated 
in this study comprised 8 (16%) men and 42 (84%) women. The mean serum levels of hs-CRP, IL-1, and IL-6 were 
0.50 ± 0.61 mg/dL, 55.02 ± 49.73 ng/L, and IL-6 39.43 ± 38.56 ng/L, respectively. The mean of VAS score was 
49.3±9.6 mm. There was no significant correlation (r = 0.05; p = 0.72) between hs-CRP serum levels and VAS 
scores. There was found a weak negative non-significant correlation (r = −0.10, p = 0.47) between IL-1 serum levels 
and VAS score. There was found a weak negative non-significant correlation (r = −0.17, p = 0.23) between IL-6 
serum levels and VAS score as well.
CONCLUSION: There was no significant correlation between serum levels of hs-CRP, IL-1, and IL-6 with VAS scores 
in patient with LBP without sciatica.
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The relationship between chronic LBP and 
increased CRP is still controversial (Figures 1-3) [7]. The 
previous studies have examined aspects of inflammatory 
pathologies such as disc herniation, inflammation of the 
nerve root, and sciatica showing a positive correlation [8]. 
Other studies have not found an association and reported 
constant levels of hs-CRP [9],[10]. Chronic LBP usually 
The cause of chronic back pain is often assumed 
to be due to degenerative conditions of the spine, but 
studies with controls have shown that the correlation 
of clinical symptoms with signs of degeneration found 
in radiology is very minimal or nonexistent. In fact, 
arthropathic inflammation, bone metabolic conditions, 
and fibromyalgia are reported as other causes of 
chronic pain conditions related to the spine. Although 
intervertebral disc herniation has long been recognized 
as a radicular pain from the spine, asymptomatic 
intervertebral disc hernias are often seen on computed 
tomography scans and magnetic resonance imaging. 
Besides that there is no clear relationship between the 
presenting of disc protrusion with the degree of severity 
of clinical symptoms. Degenerative and traumatic 
changes in the structure of the spine produce back 
pain and legs with great variety. Strict mechanical or 
pathoanatomic explanations for LBP have been shown 
to be inadequate; therefore, the role of biochemistry 
and inflammatory factors is currently being studied. 
Uncertainty in the pathoanatomic mechanism of the 
onset of pain has led to the difficulty of treating LBP to 
date [13].
By observing the above conditions, it was 
proposed by the authors to examine the relationship 
between the intensity of low back pain as measured 
using visual analog scales (VAS) and serum hs-CRP 
levels in LBP patients without sciatica. The reason for 
choosing the subject of lower back pain without sciatica 
is because the prevalence of lower back pain without 
sciatica is higher than lower back pain with sciatica 
and the relationship of LBP without sciatica with CRP 
levels is still unclear, so research is still needed. An 
estimated 5–10% of LBP is caused by sciatica, while 
the lifetime prevalence of LBP is reported to be around 
49–70% [14]. In addition, the relationship between 
increased hs-CRP and low back pain with sciatica in 
the previous studies has been reported [6]. The sciatica 
diagnosis is mainly made on the basis of history and 
physical examination [15]. The characteristic of sciatica 
pain is the pain that spreads to the legs following the 
Figure 1: Scatter diagram of the correlation between high sensitivity 
C-reactive protein levels (mg/dL) and visual analog scale score (mm)
Figure 2: Scatter diagram of a correlation between serum interleukin-1 
(ng/L) levels and visual analog scale scores (mm)
Figure 3: Scatter diagram of a correlation between serum interleukin-6 
(ng/L) levels and visual analog scale scores (mm)
results from failure of spinal surgery, degenerative 
disease of the intervertebral discs in the lumbar, arthritis, 
or spinal stenosis. If the nerve roots that come out of the 
spinal column are compressed, LBP that radiates to the 
legs will be known as lumbar radiculopathy. Inflammation 
plays a major role in the onset of radiculopathy. When 
inflammation occurs, the nerves become sensitive to 
pressure, even if only by movement or light pressure [11]. 
The local inflammation is caused by inflammatory 
mediators such as IL-6 produced by macrophages 
and monocytes at the site of inflammation. The high 
concentration of inflammatory mediators can cause 
a systemic inflammatory reaction [12]. It is therefore 
believed that hs-CRP levels are increased in patients 
with LBP.
B - ClinicalSciences Rheumatology
8 https://www.id-press.eu/mjms/index
dermatome pattern. The most important neurological 
examination on sciatica is Crossed Lasègue. It was 
reported that the specificity of the Crossed Lasègue test 
reached 88% and sensitivity of 29% [16]. Therefore, 
to rule out sciatica pain in the subject of this study, a 
neurological clinical examination was done with the 
Crossed Lasègue test.
From the description above, it can be seen that 
there is no clear relationship between mechanical and 
pathoanatomic factors with the onset of pain in patients 
with LBP. Therefore, the role of biochemical factors and 
inflammatory factors is still under research. This study 
aims to determine the relationship of serum CRP, IL-1, 
and IL-6 levels with pain intensity in patients with LBP 
without sciatica. The results of this study are expected 
to help achieve a more accurate diagnosis so that the 
management of LBP can be done optimally.
Methods
The design of this research is descriptive 
analytics with cross-sectional sampling method. We 
studied 50 sufferers of LBP with a negative Lasègue 
test on a neurological physical examination. The 
characteristics of the research subjects are in Table 1. 
The study subjects were taken from outpatients in the 
General Polyclinic of the Department of Neurology, H. 
Adam Malik Hospital Medan, who visited from April 
2019 to July 2019. The inclusion criteria in this study 
were patients with lower back pain that lasted more from 
2 months both women and men aged ≥18 years and 
signed informed consent to join the study. Patients were 
excluded from this study if: Focal neurological deficits 
were found related to back pain, patients with cancer, 
patients with chronic disease, patients with diabetes, 
patients using corticosteroids, and if the patient did not 
follow the entire study procedure to completion.
Table 1: Frequency distribution of 50 LBP patients without 
sciatica
Characteristics Frequency
Sex
Men, n (%) 8 (16)
Women, n (%) 42 (84)
Mean of age, ( ±SD) 46.72±10.79
Serum levels, (±SD)
hs-CRP (mg/dL) 0.50±0.61
IL-1 (ng/L) 55.02±49.73
IL-6 (ng/L) 39.43±3.56
The mean of VAS score, (±SD) 49.3±9.6
N: Number of patients, mean (±SD): Standard deviation, IL: Interleukin, VAS: Visual analog scale, 
hs-CRP: High sensitivity C-reactive protein, LAB: Low back pain.
This study was approved by the Medical 
Research Ethics Committee FK-USU Medan. The 
informed consent form was signed by the subjects 
after they were given an explanation of the research 
objectives and procedures. Subjects who met the 
inclusion and exclusion criteria had their blood 
sample taken for assay of serum hs-CRP, IL-1, and 
IL6 levels. Pain intensity was measured using a VAS 
score. Patients were asked to indicate the severity of 
pain experienced on a horizontal line along 100 mm 
marked from the number 0 (no pain at all) to 100 (very 
painful). VAS scores are measured in millimeters 
from the left (number 0) to right (number 100) after 
being cross-marked by the patient. The method of 
testing is for the patient to mark himself with a pencil 
on the value of pain in accordance with the intensity 
of pain he feels after being given an explanation of 
the meaning of each scale. Determination of the VAS 
score is done by measuring the distance between 
the ends of the lines that show no pain to the point 
indicated by the patient.
VAS score is an instrument used to assess 
pain intensity using a 10 cm line with a scale reading of 
0–100 mm with the following interpretation:
• 0–<10 mm: No pain
• ≥10–<30 mm: Mild pain
• ≥30–<70 mm: Moderate pain
• ≥70–<90 mm: Severe pain
• ≥90–100 mm: Very heavy pain.
hs-CRP levels were measured using Cobas 
6000 while IL-1 levels were used using the Human IL-1 
Kit, and IL-6 using the Human IL-6 Kit with the Chemwel 
2910 analyzer.
Statistical analysis
Variables hs-CRP, IL-1, IL-6, and VAS scores 
are presented in the mean and standard deviation, while 
for numerical data, the mean and standard deviation 
values are displayed.
To determine the relationship between levels of 
hs-CRP, IL-1, and IL-6 with pain intensity, the Pearson 
Correlation test was used. A significant value is stated if 
the value α is <0.05.
Results
A total of 50 LBP patients without sciatica who 
come to the Neurology Polyclinic of H. Adam Malik 
Hospital participated in this study consisting of 8 (16%) 
men and 42 (84%) women with an average age of 
46.72 ± 10.79 years. Mean serum hs-CRP was 0.50 ± 
0.61 mg/dL, mean IL-1 was 55.02 ± 49.73 ng/L, mean 
IL-6 was 39.43 ± 3.56 ng/L, and mean VAS score was 
49.3 ± 9.6 (Table 1).
From the Pearson correlation test, the VAS 
score was found to have a weak positive relationship 
(r = 0.05) association with serum hs-CRP levels which 
was nonsignificant (p = 0.72). The VAS score was found 
to have a weak negative association with IL-1 serum 
levels (r = −0.10) which was nonsignificant (p = 0.47). 
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Serum IL-6 levels also had a non-significant negative 
relationship (r = −0.17; p = 0.23) with VAS scores 
(Table 2).
Table 2: Relationships between serum hs-CRP, IL-1, and IL-6 
levels with VAS scores
hs-CRP (mg/dl) hs-CRP (mg/dl) hs-CRP (mg/dl)
VAS
r 0.05 −0.10 −0.17
p 0.72 0.47 0.23
n 50 50 50
p<0.05 (Pearson correlation test). IL: Interleukin, hs-CRP: High sensitivity C-reactive protein, VAS: Visual 
analog scale.
Discussion
The results of this study did not find a 
significant correlation between hs-CRP serum levels 
and VAS scores in patients with LBP without sciatica. 
Inflammation is closely related to the perception of 
pain, which is more likely in those with increased 
CRP levels. In a study of 99 twin pairs, it was reported 
that high CRP levels were associated with lower 
pain thresholds and increased pain perception [17]. 
Previous studies have examined aspects of 
inflammatory pathologies such as disc herniation, 
inflammation of the nerve root, and sciatica showing 
a positive correlation [8]. Other studies have not 
found an association and reported constant levels of 
hs-CRP [9], [10].
IL-1 has a weak and insignificant negative 
correlation with VAS scores in this study. Kraychete 
et al., 2010, also did not find an increase in levels of 
IL-1 in patients with chronic LBP but found an increase 
in levels of TNF-α, soluble TNF-α, and IL-6 [18].
In this study, VAS scores were found to have 
a weak but not significant negative correlation with 
IL-6. Licciardone et al., 2012, in one study, reported 
that IL-6 correlated with the severity of LBP [19]. 
A number of triggers for LBP including mechanical 
trauma, deformity, genetic predisposition, infection, 
and smoking can induce proinflammatory signaling 
in degenerative cells of intervertebral discs. The 
activity of immune cells infiltrates into the disc along 
with nerve compression; all sensitization contributes 
to pain through this mechanism if it is not triggered by 
inflammation. Because inflammation contributes to 
the pathogenesis of LBP, proinflammatory cytokines 
may be used as molecular biomarkers of pathological 
processes associated with disc degeneration, disc 
herniation, and LBP. Such proinflammatory cytokines 
can be measured in the systemic blood of patients 
with LBP [20]. In this study, serum levels of hs-CRP, 
IL-1, and IL-6 did not show a significant correlation 
with pain intensity as measured by VAS scores in 
patients with LBP without sciatica. Thus, the serum 
levels of hs-CRP, IL-1, and IL-6 cannot be used as 
molecular biomarkers in diagnosing LBP without 
sciatica.
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